Boston Partners’s Braskem BAK Stock Holding History

Boston Partners’s Portfolio BAK Stock Details BAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-140,791	Closed	-$908K	–	716
2024 Q2	$908K	Buy	+140,791	New	+$1.12M	﹤0.01%	598

Other funds holding BAK

OCM

Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return

MPM

MBB Public Markets Chicago, Illinois $839M AUM 20.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Covalis Capital London, United Kingdom $1.63B AUM 27.84% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners's BAK Position: Q3 2024 in Review

Boston Partners sold out of Braskem (BAK) in Q3 2024, closing a stake of 140,791 shares — an estimated $908K sold.

Boston Partners first reported a position in BAK in Q2 2024 and held it in 1 quarter. The position peaked at $908K in Q2 2024. 64 funds tracked by Wall St. Rank hold BAK as of Q3 2024.

Boston Partners reported no remaining Braskem position as of Q3 2024 after selling out during the quarter.
Boston Partners sold 140,791 Braskem shares in Q3 2024, an estimated $908K.
Boston Partners first reported a position in Braskem in Q2 2024 and held it in 1 quarter.
Boston Partners's Braskem position peaked at $908K in Q2 2024.
64 funds tracked by Wall St. Rank held Braskem as of Q3 2024.

Based on Boston Partners's 13F filing for Q3 2024, filed 12 Nov 2024.